Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Harding

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
BMC Nephrology|September 24, 2008
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failureColin A Hutchison, Tim Plant, Mark Drayson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 17, 2011
Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysisStephen Harding, Francois Provot, Jean-Baptise Beuscart, et al.
Journal of Clinical Pathology|August 28, 2012
Elevated, combined serum free light chain levels and increased mortality: a 5-year follow-up, UK studySeetharam Anandram, Lakhvir Kaur Assi, Tracy Lovatt, et al.
Leukemia & Lymphoma|January 7, 2016
Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survivalGuy Pratt, Peter Thomas, Nicola Marden, et al.
British Journal of Haematology|October 10, 2017
Immunoparesis defined by heavy+light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosisSajitha Sachchithanantham, Oscar Berlanga, Azra Alvi, et al.
International Journal of Molecular Sciences|April 23, 2022
SARS-CoV-2 Spike Protein Binding of Glycated Serum Albumin-Its Potential Role in the Pathogenesis of the COVID-19 Clinical Syndromes and Bias towards Individuals with Pre-Diabetes/Type 2 Diabetes and Metabolic DiseasesJason Iles, Raminta Zmuidinaite, Christoph Sadee, et al.
BMC Microbiology|September 6, 2024
​Fusarium Protein Toolkit: a web-based resource for structural and variant analysis of Fusarium speciesHye-Seon Kim, Olivia C Haley, John L Portwood Ii, et al.
Journal of Pain and Symptom Management|June 21, 2005
Improving end-of-life care: development and pilot-test of a clinical pathwayMarilyn Bookbinder, Arthur E Blank, Elizabeth Arney, et al.
Plos Medicine|February 29, 2020
Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort studyAnthony Fenton, Rajkumar Chinnadurai, Latha Gullapudi, et al.
Biochemistry|November 17, 2004
A copper protein and a cytochrome bind at the same site on bacterial cytochrome c peroxidaseSofia R Pauleta, Alan Cooper, Margaret Nutley, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
BMC Nephrology|September 24, 2008
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failureColin A Hutchison, Tim Plant, Mark Drayson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 17, 2011
Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysisStephen Harding, Francois Provot, Jean-Baptise Beuscart, et al.
Journal of Clinical Pathology|August 28, 2012
Elevated, combined serum free light chain levels and increased mortality: a 5-year follow-up, UK studySeetharam Anandram, Lakhvir Kaur Assi, Tracy Lovatt, et al.
Leukemia & Lymphoma|January 7, 2016
Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survivalGuy Pratt, Peter Thomas, Nicola Marden, et al.
British Journal of Haematology|October 10, 2017
Immunoparesis defined by heavy+light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosisSajitha Sachchithanantham, Oscar Berlanga, Azra Alvi, et al.
International Journal of Molecular Sciences|April 23, 2022
SARS-CoV-2 Spike Protein Binding of Glycated Serum Albumin-Its Potential Role in the Pathogenesis of the COVID-19 Clinical Syndromes and Bias towards Individuals with Pre-Diabetes/Type 2 Diabetes and Metabolic DiseasesJason Iles, Raminta Zmuidinaite, Christoph Sadee, et al.
BMC Microbiology|September 6, 2024
​Fusarium Protein Toolkit: a web-based resource for structural and variant analysis of Fusarium speciesHye-Seon Kim, Olivia C Haley, John L Portwood Ii, et al.
Journal of Pain and Symptom Management|June 21, 2005
Improving end-of-life care: development and pilot-test of a clinical pathwayMarilyn Bookbinder, Arthur E Blank, Elizabeth Arney, et al.
Plos Medicine|February 29, 2020
Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort studyAnthony Fenton, Rajkumar Chinnadurai, Latha Gullapudi, et al.
Biochemistry|November 17, 2004
A copper protein and a cytochrome bind at the same site on bacterial cytochrome c peroxidaseSofia R Pauleta, Alan Cooper, Margaret Nutley, et al.
Pageof 10